$LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Healthcare
Sector
Biotechnology
Industry
Roger A. Jeffs
CEO
170
Employees
$61.77
Current Price
$3.40B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 1 | 1 | $317,894.00 | 5,300 | 1:14.90 |
| Sells | 2 | 4 | $4,735,904.00 | 80,300 | ||
| 2 weeks | Buys | 1 | 1 | $317,894.00 | 5,300 | 1:86.32 |
| Sells | 3 | 15 | $27,439,836.50 | 524,193 | ||
| 1 month | Buys | 1 | 1 | $317,894.00 | 5,300 | 1:99.58 |
| Sells | 5 | 21 | $31,655,897.98 | 626,457 | ||
| 2 months | Buys | 1 | 1 | $317,894.00 | 5,300 | 1:172.80 |
| Sells | 10 | 46 | $54,933,641.28 | 1,217,383 | ||
| 3 months | Buys | 1 | 1 | $317,894.00 | 5,300 | 1:192.49 |
| Sells | 11 | 58 | $61,192,643.48 | 1,391,798 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Apr 10, 2026 | JEFFS ROGER Director | Sale | 21,433 | $40.12 | $859,876.96 | View Details |
| Apr 9, 2026 | JEFFS ROGER Director | Sale | 25,000 | $40.12 | $1,002,887.50 | View Details |
| Apr 9, 2026 | Kaseta Michael CFO and COO | Sale | 133,789 | $40.24 | $5,383,388.40 | View Details |
| Mar 27, 2026 | Bloch Stephen M Director | Sale | 30,176 | $36.38 | $1,097,676.14 | View Details |
| Mar 26, 2026 | Bloch Stephen M Director | Sale | 7,684 | $37.22 | $285,985.42 | View Details |
| Mar 27, 2026 | Bloch Stephen M Director | Sale | 1,973 | $37.13 | $73,258.08 | View Details |
| Mar 27, 2026 | Bloch Stephen M Director | Sale | 30,401 | $35.42 | $1,076,845.98 | View Details |
| Mar 23, 2026 | Moomaw Scott Chief Commercial Officer | Sale | 1,314 | $36.48 | $47,934.72 | View Details |
| Mar 23, 2026 | Moomaw Scott Chief Commercial Officer | Sale | 17,000 | $36.81 | $625,817.60 | View Details |
| Mar 13, 2026 | Saggar Rajeev Chief Medical Officer | Sale | 35,365 | $36.30 | $1,283,834.38 | View Details |
| Mar 13, 2026 | Krepp Sarah Chief Human Resource Officer | Sale | 16,261 | $38.00 | $617,918.00 | View Details |
| Mar 13, 2026 | SINGH RAMAN Director | Sale | 20,000 | $36.04 | $720,828.00 | View Details |
| Mar 9, 2026 | Moomaw Scott Chief Commercial Officer | Sale | 80,000 | $35.32 | $2,825,824.00 | View Details |
| Mar 2, 2026 | Krepp Sarah Chief Human Resource Officer | Sale | 276 | $30.58 | $8,440.08 | View Details |
| Mar 2, 2026 | Boyle Dana Chief Accounting Officer | Sale | 445 | $30.58 | $13,608.10 | View Details |
| Mar 2, 2026 | Moomaw Scott Chief Commercial Officer | Sale | 827 | $30.58 | $25,289.66 | View Details |
| Mar 2, 2026 | Schundler Russell General Counsel | Sale | 1,073 | $30.58 | $32,812.34 | View Details |
| Mar 2, 2026 | Kaseta Michael CFO and COO | Sale | 1,165 | $30.58 | $35,625.70 | View Details |
| Mar 2, 2026 | Adair Jason Chief Business Officer | Sale | 689 | $30.58 | $21,069.62 | View Details |
72 more transactions available โ create a free account to see 12 months of history | ||||||
Showing 41โ59 of 59 transactions
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated$0.01
ActualN/A
Revenue
EstimatedN/A
ActualN/A